Search

everythinglearnresearchcommunity

for

Search:↓

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Stem cells slowed lung tumor growth but increased colon tumor growth in mice.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Carriers of a specific gene mutation have subtle skin changes without visible symptoms.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Noggin promotes skin tumors by activating certain cell signaling pathways.

The research suggests that a specific skin gene can be controlled by signals within and between cells and is wrongly activated in certain skin diseases.

Laser therapy on human skin affects the HERC6 gene and related genes, influencing many cell processes and requiring careful safety measures.

Specific mutations in a receptor cause facial abnormalities and hair loss.

Atg5 can promote tumors when autophagy is deficient but suppresses them under normal conditions.

Activating ER-β, not ER-α, improves skin cell growth and wound healing.

The research suggests that p63 and TGF-β1 may help determine tumor type and malignancy in hair follicle and sebaceous tumors.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

Estrogen and androgenic hair increase melanoma risk, especially in European-ancestry individuals.

Cox-2 significantly contributes to the development and progression of skin and esophageal cancers.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Gasdermin A3 overexpression in skin causes inflammation and hair loss.

Abnormal activation of hair follicle stem cells and Wnt/β-catenin signaling contributes to sebaceous neoplasms.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Stat3 influences keratinocyte stem cell behavior, affecting differentiation and migration.

A new gene mutation causes insulin resistance in a girl and her mother.